Takeda has made a strong play for a stake in the Alzheimer’s disease market, paying $100 million upfront for an option on AC ...

Leela Barham looks at the speediness of NICE’s technology appraisals and ongoing efforts to hit the target of NICE publishing ...

Monitoring of heart failure patients in their homes using a wearable developed by Analog Devices Inc (ADI) has shown in a new ...

The first person to receive a transplant of a kidney from a pig has died almost two months after the procedure, although the ...

Sanofi will invest more than €1 billion ($1.08 billion) in new bioproduction capacity at three manufacturing sites in France ...

The fear for shareholders is that a delay could mean that mRNA-1345 won’t be ready to roll out in the US in time for the ...

Three years after turning it down for being too expensive, NICE has backed the use of Pfizer’s Vyndaqel as a treatment for ...

The latest version of Google DeepMind and Isomorphic Labs’ AlphaFold model can predict the structure and relationships not ...

Sanofi has licensed joint commercial rights to Novavax’s COVID-19 vaccine and will work with the biotech on the development ...

Bluejay Therapeutics has completed a sizeable third-round financing, raising $182 million that will be used for clinical ...

The Immigration Salary List has replaced the Shortage Occupation List with a significant reduction of SOC Codes on the list.

MSD for Mothers’ goal is to help meet the United Nations’ Sustainable Development Goal target of reducing the global maternal ...